Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
NCT01484678
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease progression and to serve as an objective outcome measure for clinical trials in Muscular Dystrophy (MD). The investigators will compare the muscles of ambulatory or non-ambulatory boys/men with DMD with muscles of healthy individuals of the same age and monitor disease progression in those with DMD over a 5-10 year period.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Duchenne Muscular Dystrophy
- Becker Muscular Dystrophy
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 5 to 62 years
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- University of Florida
- Last updated on ClinicalTrials.gov
- October 15, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- University of Florida · Gainesville, FL
Oregon · 1
- Oregon Health and Science University · Portland, OR
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.